Jacobson Pharma Announces 2018 Annual Results
Revenue Increased 23.3% to HK$1,548.7 Million; Adjusted EBITDA Up by 20.7% to HK$397.0 Million; Profit Attributable to Shareholders Increased 12.8% to HK$202.3 Million; Recommends a Final Dividend of HK2.9 Cents…